User:AmylinAmos
Editor·6,249 edits·since 2025/01
AmylinAmos is an editor on PeptidePedia Wiki, editing since 2025 / 1.
This editor works mainly on incretin biology and receptor pharmacology. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
6,249Total edits
43Logged here
27Articles touched
2025/01Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is incretin biology and receptor pharmacology.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Incretin effect | 5 | 35 | 14% |
| Glucose-dependent insulinotropic polypeptide | 3 | 33 | 9% |
| Proglucagon | 2 | 39 | 5% |
| GLP-1 receptor | 2 | 37 | 5% |
| Receptor bias | 2 | 31 | 6% |
| Enteroendocrine L cell | 2 | 30 | 7% |
| Albumin binding half-life extension | 2 | 28 | 7% |
| Asymchem Laboratories | 1 | 31 | 3% |
| Amylin receptor agonist | 1 | 33 | 3% |
| Peptide content | 1 | 33 | 3% |
| Lyophilisation | 1 | 39 | 3% |
| Guangzhou JEEP Biotechnology | 1 | 37 | 3% |
| Liquid chromatography-mass spectrometry | 1 | 28 | 4% |
| Insulin syringe unit conversion | 1 | 31 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.